Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...
Four musicians walk into a room. They start to talk, but without words. No narrator, no conductor. Just music. They watch ...